Katowickie Centrum Onkologii

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Triple-negative breast cancer1 trial

Phase

• Phase 32 trials
• Phase 2/31 trial

Status

• Recruiting2 trials
• Suspended1 trial

Lead sponsor

• BioNTech SE3 trials

Running trials

• Recruiting

  ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

  NCT07173751· Phase 3· BioNTech SE· Source

• Recruiting

  Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

  NCT06712316· Phase 2/3· BioNTech SE· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer1 recruiting
• Triple-negative breast cancer1 recruiting